AbbVie Inc. et al v. Alvotech hf. > Summary

Court Case Number 1:21-cv-02899

Filing Date May 28, 2021

Termination Date Mar 9, 2022

Court Illinois Northern District Court

Status Dismissed - Other

JudgesJohn Lee, M. David Weisman, Franklin U. Valderrama

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
11191834	Protein formulations and methods of making same	Dec 7, 2021
11167030	Protein formulations and methods of making same	Nov 9, 2021
11147782	GHB formulation and method for its manufacture	Oct 19, 2021
11083792	Purified antibody composition	Aug 10, 2021
09957318	Protein purification methods to reduce acidic species	May 1, 2018
09708400	Methods to modulate lysine variant distribution	Jul 18, 2017
09683033	Cell culture methods to reduce acidic species	Jun 20, 2017
09669093	Methods for treating juvenile idiopathic arthritis	Jun 6, 2017
09624295	Uses and compositions for treatment of psoriatic arthritis	Apr 18, 2017
09550826	Glycoengineered binding protein compositions	Jan 24, 2017
09546212	Methods of administering anti-TNFα antibodies	Jan 17, 2017
09522953	Low acidic species compositions and methods for producing and using the same	Dec 20, 2016
09512216	Use of TNFα inhibitor	Dec 6, 2016
09505834	Methods for controlling the galactosylation profile of recombinantly-expressed proteins	Nov 29, 2016
09499616	Modulated lysine variant species compositions and methods for producing and using the same	Nov 22, 2016
09499614	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides	Nov 22, 2016
09359434	Cell culture methods to reduce acidic species	Jun 7, 2016
09346879	Protein purification methods to reduce acidic species	May 24, 2016
09339610	Removal of needle shield from syringes and automatic injection devices	May 17, 2016
09334319	Low acidic species compositions	May 10, 2016
09328165	Purified antibody composition	May 3, 2016
09315574	Low acidic species compositions and methods for producing and using the same	Apr 19, 2016
09290568	Methods to control protein heterogeneity	Mar 22, 2016
09284371	Methods of producing adalimumab	Mar 15, 2016
09284370	Methods for treating juvenile idiopathic arthritis	Mar 15, 2016
09273132	Purified antibody composition	Mar 1, 2016
09266949	Low acidic species compositions and methods for producing and using the same	Feb 23, 2016
09234032	Fed-batch methods for producing adalimumab	Jan 12, 2016
09187559	Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease	Nov 17, 2015
09181337	Modulated lysine variant species compositions and methods for producing and using the same	Nov 10, 2015
09181572	Methods to modulate lysine variant distribution	Nov 10, 2015
09150645	Cell culture methods to reduce acidic species	Oct 6, 2015
09102723	Purified antibody composition	Aug 11, 2015
09096666	Purified antibody composition	Aug 4, 2015
09090867	Fed-batch method of making anti-TNF-alpha antibody	Jul 28, 2015
09090688	Methods for controlling the galactosylation profile of recombinantly-expressed proteins	Jul 28, 2015
09090689	Use of TNFα inhibitor for treatment of psoriasis	Jul 28, 2015
09085619	Anti-TNF antibody formulations	Jul 21, 2015
09085620	Use of TNFα inhibitor for treatment of psoriatic arthritis	Jul 21, 2015
09085618	Low acidic species compositions and methods for producing and using the same	Jul 21, 2015
09067992	Use of TNFα inhibitor for treatment of psoriatic arthritis	Jun 30, 2015
09062106	Methods for controlling the galactosylation profile of recombinantly-expressed proteins	Jun 23, 2015
09061005	Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease	Jun 23, 2015
08999337	Methods for treating juvenile idiopathic arthritis by inhibition of TNFα	Apr 7, 2015
08992926	Methods of administering anti-TNFα antibodies	Mar 31, 2015
08986693	Use of TNFα inhibitor for treatment of psoriasis	Mar 24, 2015
08974790	Methods of administering anti-TNFα antibodies	Mar 10, 2015
08961973	Multiple-variable dose regimen for treating TNFα-related disorders	Feb 24, 2015
08961974	Multiple-variable dose regimen for treating TNFα-related disorders	Feb 24, 2015
08926975	Method of treating ankylosing spondylitis	Jan 6, 2015
08916153	Purified antibody composition	Dec 23, 2014
08911737	Methods of administering anti-TNFα antibodies	Dec 16, 2014
08911964	Fed-batch method of making human anti-TNF-alpha antibody	Dec 16, 2014
08906646	Fed-batch method of making human anti-TNF-alpha antibody	Dec 9, 2014
08906373	Use of TNF-alpha inhibitor for treatment of psoriasis	Dec 9, 2014
08906372	Purified antibody composition	Dec 9, 2014
08895009	Purified antibody composition	Nov 25, 2014
08889136	Multiple-variable dose regimen for treating TNFα-related disorders	Nov 18, 2014
08883156	Purified antibody composition	Nov 11, 2014
08808700	Use of TNF alpha inhibitor for treatment of erosive polyarthritis	Aug 19, 2014
08715664	Use of human TNFα antibodies for treatment of erosive polyarthritis	May 6, 2014
08708968	Removal of needle shields from syringes and automatic injection devices	Apr 29, 2014
08663945	Methods of producing anti-TNF-alpha antibodies in mammalian cell culture	Mar 4, 2014
08420081	Antibody formulations and methods of making same	Apr 16, 2013
08231876	Purified antibody composition	Jul 31, 2012
06805686	Autoinjector with extendable needle protector shroud	Oct 19, 2004

Lawsuits

AbbVie Inc. et al v. Alvotech hf. > Summary

Plaintiff

Defendant

Plaintiff Attorneys

Defendant Attorneys

Counter Defendant

Counter Claimant

Cause

Related Patents